2-[3-[4-[2,6-bis(3-methylbutyl)phenyl]pyrazol-1-yl]phenoxy]-9-(4-propyl-2-pyridinyl)carbazole
C45H48N4O — CID 153413769
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-[4-[2,6-bis(3-methylbutyl)phenyl]pyrazol-1-yl]phenoxy]-9-(4-propyl-2-pyridinyl)carbazole
2-[3-[4-[2,6-bis(3-methylbutyl)phenyl]pyrazol-1-yl]phenoxy]-9-(4-propyl-2-pyridinyl)carbazole (PubChem CID 153413769) has the molecular formula C45H48N4O and a molecular weight of 660.91 g/mol. Its IUPAC name is 2-[3-[4-[2,6-bis(3-methylbutyl)phenyl]pyrazol-1-yl]phenoxy]-9-(4-propyl-2-pyridinyl)carbazole.
Molecular Properties
| Compound Name | 2-[3-[4-[2,6-bis(3-methylbutyl)phenyl]pyrazol-1-yl]phenoxy]-9-(4-propyl-2-pyridinyl)carbazole |
|---|---|
| PubChem CID | 153413769 |
| Molecular Formula | C45H48N4O |
| Molecular Weight | 660.91 g/mol |
| Exact Mass | 660.38 |
| IUPAC Name | 2-[3-[4-[2,6-bis(3-methylbutyl)phenyl]pyrazol-1-yl]phenoxy]-9-(4-propyl-2-pyridinyl)carbazole |
| SMILES | CCCc1ccnc(-n2c3ccccc3c3ccc(Oc4cccc(-n5cc(-c6c(CCC(C)C)cccc6CCC(C)C)cn5)c4)cc32)c1 |
| InChI | InChI=1S/C45H48N4O/c1-6-11-33-24-25-46-44(26-33)49-42-17-8-7-16-40(42)41-23-22-39(28-43(41)49)50-38-15-10-14-37(27-38)48-30-36(29-47-48)45-34(20-18-31(2)3)12-9-13-35(45)21-19-32(4)5/h7-10,12-17,22-32H,6,11,18-21H2,1-5H3 |
| InChIKey | WGNCRIOPCKGNQO-UHFFFAOYSA-N |
| XLogP | 11.95 |
| TPSA | 44.87 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 660.91 |
| LogP ≤ 5 | 11.95 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153413769 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.